Fatty liver disease, specifically non-alcoholic fatty liver disease (NAFLD), is a condition that has quietly become a major health concern.
About one in four people around the world have it, and it’s not something to be ignored. If left untreated, it can pave the way for all sorts of other health problems like type 2 diabetes, heart issues, and even liver cancer.
The tricky part? In its early stages, you probably won’t even know you have it because there are usually no symptoms.
Right now, the only known way to deal with NAFLD is through lifestyle changes like exercise and eating fewer calories. But these changes only really help in the early stages of the disease.
There’s no medication to treat it once it advances to a more serious stage, known as NASH (non-alcoholic steatohepatitis). That’s why scientists are on the hunt for new ways to treat it.
The Big Discovery: Adgrf1
Researchers led by Mengyao Wu from Guangzhou University in China think they might be onto something. They’ve been studying a molecule, mainly found in the liver, called Adgrf1.
When they fed mice a high-fat diet, the levels of this molecule in the liver dropped sharply, indicating that it could be a sign of NAFLD.
This is a big deal because if they can understand how this molecule works, they might be able to create a drug that targets it to treat or even prevent fatty liver disease.
But it doesn’t end there. The scientists also manipulated the levels of Adgrf1 in mice. When they did this, the mice showed clear signs of diabetes, like higher sugar and insulin levels.
This suggests that Adgrf1 plays a role in how the body processes fat and sugar. They even went further and used a technique to block Adgrf1 in mice that already had fatty liver disease. Guess what? Their liver health improved.
To confirm that this wasn’t just a mouse thing, the researchers looked at liver samples from humans at different stages of NAFLD.
What they found was consistent with their mouse studies. People with severe fatty liver disease had higher levels of Adgrf1.
Why Does This Matter?
This is huge because it opens up a new door for treating fatty liver disease. Since Adgrf1 is mostly found in the liver, a drug that targets it would likely have fewer side effects on other organs.
If further studies confirm these findings, it could lead to a new medication that could be a game-changer for people with this disease.
The next steps are to dig deeper into how exactly Adgrf1 works and to develop safe and effective ways to target it with medication.
If this works out, it could offer a ray of hope for millions of people worldwide suffering from fatty liver disease, offering them a treatment option where none currently exists.
If you care about liver health, please read studies about dairy foods linked to liver cancer, and coffee drinkers may halve their risk of liver cancer.
For more information about liver health, please see recent studies that an anti-inflammatory diet could help prevent fatty liver disease, and results showing vitamin D could help prevent non-alcoholic fatty liver disease.
The study was published in eLife.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
